+919405117673
Nefroheal Alpha Ketoanalogue Tablets 200 mg – Trusted Kidney Care Supplement | Global Export
Cordium Pharmaceuticals Pvt Ltd is a leading global pharmaceutical exporter from India, delivering high-quality Nefroheal Alpha Ketoanalogue Tablets 200 mg to hospitals, pharmacies, and medical institutions across the world with fast and reliable international shipping.

We ensure consistent supply and premium manufacturing standards trusted by healthcare professionals globally.

🌍 Global Export Destinations

We proudly supply to:
United States, United Kingdom, South Africa, Russia, Nigeria, France, Netherlands, Canada, Australia, Brazil and many more countries worldwide.

πŸ’Š Product Information: Nefroheal Alpha Ketoanalogue Tablets 200 mg
βœ” Usage

Nefroheal Alpha Ketoanalogue Tablets are commonly used as a nutritional therapeutic supplement to support patients with chronic kidney conditions, especially those advised protein-restricted diets. It helps in reducing the buildup of toxic nitrogenous waste in the body.

βœ” Dosage
Typically taken as directed by a qualified physician
Usually recommended during meals to improve absorption
Dosage varies depending on kidney condition severity, age, and medical prescription
⚠️ Always follow doctor’s prescription strictly
⚠️ Possible Side Effects

Some users may experience:

Nausea
Vomiting
Abdominal discomfort
Mild hypercalcemia (rare cases)
Allergic reactions (very rare)

If any severe symptoms occur, discontinue use and consult a healthcare professional immediately.

πŸ₯ About Cordium Pharmaceuticals Pvt Ltd

A trusted Indian pharmaceutical exporter committed to delivering high-quality, WHO-GMP certified pharmaceutical products globally with fast delivery support to hospitals, pharmacies, and healthcare institutions.

πŸ“¦ Fast International Delivery Available

We ensure quick and safe export supply chain management for urgent hospital and institutional requirements.

πŸ“ž Contact for Bulk Orders & Export Inquiry

πŸ“± WhatsApp: +91-9405117673
πŸ“§ Email: info@cordiumpharma.com
Apr 20th, 2026 5:20 PM

Keywords